Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs VEU✓SelectedUSD · VEUGSK vs VEU performance historyLatest closeAs of-1.34%11/18
Stock and ETF performance explorer

GSK vs VEU

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+102.1%
VEU return
+139.8%
Excess return
-37.7%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioVEUExcessAlpha
1D-1.3%-1.1%-0.3%-0.7%
7D-3.1%-5.0%+1.9%-0.2%
30D-0.9%-4.7%+3.8%+1.8%
3M-4.2%-7.9%+3.8%+0.3%
6M-1.6%-4.1%+2.5%0.0%
YTD+2.6%+6.3%-3.7%-2.3%
1Y+6.2%+11.4%-5.2%-1.6%
3Y+55.0%+57.2%-2.2%+15.8%
5Y+42.8%+43.3%-0.4%+12.0%
10Y+102.1%+140.5%-38.4%+11.2%
All+102.1%+139.8%-37.7%+11.2%

Cumulative growth

Daily Returns

Daily percentage return beside VEU.

Daily Out/Under-Performance

Portfolio return minus VEU return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × VEU return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded VEU wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling